efaproxiral has been researched along with lonafarnib in 1 studies
Studies (efaproxiral) | Trials (efaproxiral) | Recent Studies (post-2010) (efaproxiral) | Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) |
---|---|---|---|---|---|
76 | 13 | 10 | 224 | 34 | 90 |
Protein | Taxonomy | efaproxiral (IC50) | lonafarnib (IC50) |
---|---|---|---|
Chain A, Protein farnesyltransferase alpha subunit | Rattus norvegicus (Norway rat) | 0.0019 | |
Chain B, Protein farnesyltransferase beta subunit | Rattus norvegicus (Norway rat) | 0.0019 | |
GTPase HRas | Homo sapiens (human) | 0.07 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.7 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Bos taurus (cattle) | 0.0081 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.1498 | |
Protein farnesyltransferase subunit beta | Bos taurus (cattle) | 0.0081 | |
Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.1498 | |
Protein farnesyltransferase subunit beta | Rattus norvegicus (Norway rat) | 0.0019 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Rattus norvegicus (Norway rat) | 0.0019 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nestler, HP | 1 |
1 other study(ies) available for efaproxiral and lonafarnib
Article | Year |
---|---|
Hit to Lead Success Stories--IBC Conference: Effective chemistry strategies for reducing attrition rates and speeding lead compounds into the pipeline. 31 January-1 February 2005, San Diego, CA, USA.
Topics: Aniline Compounds; Bradykinin; Drug Approval; Drug Design; Drug Evaluation; Humans; Molecular Structure; Piperidines; Propionates; Pyridines; Time Factors | 2005 |